Boc-Lys(Z)-OH (DCHA) |
| Catalog No.GC66483 |
Boc-Lys(Z)-OH (DCHA) participa en la síntesis de fragmentos de timosina β4, βgy β6 y aumenta la capacidad de formación de rosetas E en el modelo de nefritis lúpica. Boc-Lys(Z)-OH (DCHA) participa en la síntesis de Boc-Lyz-OCH3 y actúa como reactivo de la producción de inhibidores de peptidil trombina.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 16948-04-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Boc-Lys(Z)-OH (DCHA) is a involves in synthesis thymosin β4, βg and β6 fragments, and increases E-rosette forming capacity in Lupus Nephritis model. Boc-Lys(Z)-OH (DCHA) involves in synthesis Boc-Lyz-OCH3 and acts as a reagent of peptidyl thrombin inhibitors production[1][2][3].
[1]. Abiko, et al. Synthesis of six common amino acid sequence fragments of thymosins beta 4, beta 8 and beta 9 and determination of their effects on the low E-rosette forming cells of lupus nephritis patients. Chemical & pharmaceutical bulletin, 1984.
[2]. Cal PM, et al. Iminoboronates: a new strategy for reversible protein modification. J Am Chem Soc. 2012 Jun 20;134(24):10299-305.
[3]. Van Boeckel, et al. Preparation of peptidyl thrombin inhibitors: World Intellectual Property Organization, WO9807308. 1998-02-26.
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *